FDA Recall Open, Classified

The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a tissue anchor to the ligaments of the vaginal cavity. The anchors are pre-loaded inside the device shaft and are ready for use. A thimble is also supplied, as an accessory for the device, to be used as a guide channel for better handling of the EnPlace. Intended Use / Indications for Use: The EnPlace system is intended for attaching sutures to ligaments of the pelvic floor.

Recall: Z-0556-2022 · Initiated December 13, 2021

Recall

Recall Number
Z-0556-2022
Event Number
89309
Firm
FEMSelect Ltd HaMa'ayan 2 First Floor Modi'in Israel
FEI Number
3010892271
Product Code
PBQ
Status
Open, Classified
Root Cause
Process design
Initiated
December 13, 2021

Description

The EnPlace is a single use trans-vaginal pelvic floor repair system which enables delivery of a tissue anchor to the ligaments of the vaginal cavity. The anchors are pre-loaded inside the device shaft and are ready for use. A thimble is also supplied, as an accessory for the device, to be used as a guide channel for better handling of the EnPlace. Intended Use / Indications for Use: The EnPlace system is intended for attaching sutures to ligaments of the pelvic floor.

Reason

Certain lots may not have been packaged wth the Channel Tube Limiter.

Action

On Monday, December 13, 2021, FEMSelect alerted the US distributor both by phone and with a letter sent by email. The formal Recall Notice was sent on December 14, 2021. The recalling firm is requesting the return of the devices.

Distribution

US Nationwide distribution in the state of Georgia.

Quantity

141 units